Ruohola H, Kabcenell A K, Ferro-Novick S
Department of Cell Biology, Yale University School of Medicine, New Haven, Connecticut 06510.
J Cell Biol. 1988 Oct;107(4):1465-76. doi: 10.1083/jcb.107.4.1465.
Using either permeabilized cells or microsomes we have reconstituted the early events of the yeast secretory pathway in vitro. In the first stage of the reaction approximately 50-70% of the prepro-alpha-factor, synthesized in a yeast translation lysate, is translocated into the endoplasmic reticulum (ER) of permeabilized yeast cells or directly into yeast microsomes. In the second stage of the reaction 48-66% of the ER form of alpha-factor (26,000 D) is then converted to the high molecular weight Golgi form in the presence of ATP, soluble factors and an acceptor membrane fraction; GTP gamma S inhibits this transport reaction. Donor, acceptor, and soluble fractions can be separated in this assay. This has enabled us to determine the defective fraction in sec23, a secretory mutant that blocks ER to Golgi transport in vivo. When fractions were prepared from mutant cells grown at the permissive or restrictive temperature and then assayed in vitro, the acceptor Golgi fraction was found to be defective.
我们使用通透细胞或微粒体在体外重建了酵母分泌途径的早期事件。在反应的第一阶段,在酵母翻译裂解物中合成的约50 - 70%的前原α因子被转运到通透酵母细胞的内质网(ER)中,或直接进入酵母微粒体。在反应的第二阶段,在ATP、可溶性因子和受体膜组分存在的情况下,48 - 66%的α因子ER形式(26,000 D)随后转化为高分子量的高尔基体形式;GTPγS抑制这种转运反应。在该测定中可以分离供体、受体和可溶组分。这使我们能够确定sec23中的缺陷组分,sec23是一种在体内阻断内质网到高尔基体转运的分泌突变体。当从在允许温度或限制温度下生长的突变细胞中制备组分,然后在体外进行测定时,发现受体高尔基体组分存在缺陷。